EHRA Premium Access

Effectiveness and safety of edoxaban in 27,333 patients from ETNA-AF with and without a history of intracranial haemorrhage after 2 years of treatment

Topic: Oral Anticoagulation

Congress Presentation

About the speaker

Doctor Julia Moser

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)
0 follower

5 more presentations in this session

Left atrial thrombus in atrial fibrillation/flutter patients in relation to anticoagulation strategy: LATTEE registry

Speaker: Doctor M. Gawalko (Warsaw, PL)


Detection of atrial fibrillation in patients with cryptogenic stroke: The Nordic Atrial Fibrillation and Stroke (NOR-FIB) study - topline results

Speaker: Doctor B. Ratajczak-Tretel (Sarpsborg, NO)


Oral anticoagulants in older patients with atrial fibrillation: insights from a nationwide study

Speaker: Doctor P. Rasmussen (Copenhagen, DK)


Adherence to oral anticoagulation in a Belgium atrial fibrillation population measured by a medical event monitoring system

Speaker: Miss L. Knaepen (Hasselt, BE)


Systolic blood pressure and effects of screening for atrial fibrillation with long-term continuous monitoring

Speaker: Mr L. Xing (Copenhagen, DK)


Access the full session

What is new on stroke prevention

Speakers: Doctor J. Moser, Doctor M. Gawalko, Doctor B. Ratajczak-Tretel, Doctor P. Rasmussen, Miss L. Knaepen...

About the event


EHRA 2022

3 April - 5 April 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb